Chai Discovery vs Ankr

Side-by-side comparison of AI visibility scores, market position, and capabilities

Chai Discovery leads in AI visibility (69 vs 33)
Chai Discovery logo

Chai Discovery

ChallengerHealthcare Tech

AI Molecular Discovery

AI molecular discovery unicorn ($1.3B valuation). 100x improvement in de novo antibody design success. Backed by OpenAI. Eli Lilly partnership. Founded 2023, SF. $225M+ raised.

AI VisibilityBeta
Overall Score
B69
Category Rank
#1 of 1
AI Consensus
77%
Trend
up
Per Platform
ChatGPT
74
Perplexity
74
Gemini
73

About

Chai Discovery is an AI-driven molecular discovery company founded in 2024 and headquartered in San Francisco. The company was spun out of research conducted by scientists with backgrounds at leading computational biology and AI organizations, with the founding mission of applying the latest advances in generative AI to accelerate drug discovery — particularly the historically difficult challenge of designing novel antibodies and small molecules from scratch rather than optimizing known chemical scaffolds.\n\nChai's core technology is a foundation model for molecular structure prediction and de novo design that operates across proteins, small molecules, nucleic acids, and their complexes. The company's flagship research achievement is a reported 100-fold improvement in de novo antibody design success rates, enabling the generation of functional antibody candidates without requiring extensive experimental screening campaigns. Chai Discovery has established a research partnership with Eli Lilly, one of the world's largest pharmaceutical companies, to apply its platform to therapeutic target programs. The company is backed by OpenAI, reflecting the deep connection between large-scale AI modeling techniques and the biological sequence-structure-function prediction task.\n\nChai Discovery reached a $1.3 billion valuation within its first year of operation, an exceptionally rapid ascent reflecting the strategic premium investors place on AI-native molecular discovery platforms. The company operates at the intersection of structural biology, generative AI, and therapeutic development, competing with platforms like Isomorphic Labs, Recursion, and Insilico Medicine in the race to demonstrate AI-designed drugs in human clinical trials.

Full profile
Ankr logo

Ankr

EmergingWeb3

Multi-Chain RPC Infrastructure

Decentralized Web3 infrastructure with RPC node access across 30+ blockchains; globally distributed nodes reduce latency; premium dedicated nodes for apps needing guaranteed throughput.

AI VisibilityBeta
Overall Score
D33
Category Rank
#1 of 1
AI Consensus
56%
Trend
up
Per Platform
ChatGPT
40
Perplexity
40
Gemini
29

About

Ankr is a Web3 infrastructure platform offering remote procedure call node access to more than 30 blockchain networks through a globally distributed network of nodes run by independent operators. Unlike centralized providers that operate their own data centers exclusively, Ankr's decentralized architecture routes requests across geographically distributed nodes, improving latency for users in regions underserved by US- or EU-centric infrastructure. Its public free-tier RPC endpoints — available for Ethereum, BNB Chain, Polygon, Avalanche, Fantom, and dozens of others — have made Ankr one of the most widely used infrastructure providers in the multi-chain developer ecosystem.

Full profile

AI Visibility Head-to-Head

69
Overall Score
33
#1
Category Rank
#1
77
AI Consensus
56
up
Trend
up
74
ChatGPT
40
74
Perplexity
40
73
Gemini
29
65
Claude
25
70
Grok
40

Key Details

Category
AI Molecular Discovery
Multi-Chain RPC Infrastructure
Tier
Challenger
Emerging
Entity Type
brand
brand

Capabilities & Ecosystem

Capabilities

Only Chai Discovery
AI Molecular Discovery
Only Ankr
Multi-Chain RPC Infrastructure

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.